Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Table 1 Demographic data of patients included

Parameters	PD Group (n = 24)	NPD Group (n = 23)	P
Age (y)	56.4 ± 5.8	56.3 ± 5.0	0.943
Height (cm)	168.7 ± 5.1	169.4 ± 3.8	0.608
Weight (kg)	66.3 ± 9.8	70.1 ± 8.3	0.110
BMI (kg.m⁻²)	23.2 ± 2.7	24.6 ± 2.7	0.088
ASA physical status (II/III)	19/5	17/6	0.671

Data are presented as mean ± SD or number
PD Parkinson’s disease, NPD non- Parkinson’s disease, BMI Body mass index, ASA American Society of Anesthesiologists

ISSN: 1471-2253